Stockreport

How Revenue Assumptions Are Rewriting The Story For Castle Biosciences (CSTL) [Yahoo! Finance]

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report
PDF Castle Biosciences is back in focus as one firm's price target shift from US$35 to US$52 draws attention to how small changes in revenue assumptions can reshape upside [Read more]